An immune response dominated by TH1 helper T-cells and CD8+ cytotoxic T-cells is often correlated with inhibition of tumor growth and complete tumor regression both in mice and humans (21), while a response dominated by T-regulatory cells (FOXP3+) is often neutral or even negatively correlated with patient overall survival (22). The gene discussed is CD8A; the disease is neoplasm.